- The Trump administration’s decision to encourage states to move to Medicaid block grants is likely to be challenged in court, but it’s not clear if critics have to wait for a state to implement such a plan before they can seek a judicial review.
- One item in the administration’s announcement on Medicaid that is likely to win support among both liberal and conservative local officials would be the ability of state programs to limit their prescription drug formularies. Even some progressive states, such as Massachusetts, have called for that flexibility, although they are not likely to want to move to a block grant.
- As the new coronavirus outbreak in China makes headlines in the U.S., it’s important to note that scientists still have many things to learn about the virus, including how dangerous it is. China does not seem to be monitoring or counting the number of mild cases of infection, so it’s difficult to determine how lethal the virus is.
- The effort by China to quarantine areas hit by the coronavirus and other countries’ travel and trade restrictions are hard to enforce — and they may create difficulties in fighting the spread of disease if infected people subvert the limits on movement without officials realizing what’s happening.
- The Supreme Court this week gave a temporary green light to the Trump administration’s rule to consider whether immigrants seeking residency in the U.S. have used public assistance programs, such as Medicaid or food stamps. But that is not the court’s final word on what’s known as the “public charge” rule. It is merely allowing the program to go forward while it is evaluated by lower courts.
- As anti-abortion supporters rallied in Washington last week, the administration announced its plan to cut funds to California over the abortion issue. Federal officials are expected to notify a half-dozen other states with similar rules for insurers that they could face the same consequences.
- Share on X (Opens in new window) X
- Share on Facebook (Opens in new window) Facebook
- Share on LinkedIn (Opens in new window) LinkedIn
- Email a link to a friend (Opens in new window) Email
- Print (Opens in new window) Print
Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact NewsWeb@kff.org.